Walleye Capital
SRTAW

Walleye Capital’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Walleye Capital’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-188,816
Closed -$77.4K – 4285
2024
Q4 		$77.4K Sell
188,816
-1,966,850
-91% -$656K ﹤0.01% 4229
2024
Q3 		$410K Hold
2,155,666
– – ﹤0.01% 3483
2024
Q2 		$364K Sell
2,155,666
-1,000
-0% -$257 ﹤0.01% 3790
2024
Q1 		$225K Sell
2,156,666
-147,273
-6% -$25K ﹤0.01% 3898
2023
Q4 		$806K Sell
2,303,939
-92,137
-4% -$26.3K ﹤0.01% 2546
2023
Q3 		$551K Buy
2,396,076
+393,510
+20% +$185K ﹤0.01% 2741
2023
Q2 		$1.27M Buy
2,002,566
+232,247
+13% +$104K ﹤0.01% 1648
2023
Q1 		$850K Buy
1,770,319
+65,471
+4% +$40.4K 0.01% 1293
2022
Q4 		$852K Buy
1,704,848
+173,687
+11% +$111K 0.02% 1096
2022
Q3 		$980K Buy
1,531,161
+107,422
+8% +$91K 0.02% 985
2022
Q2 		$954K Buy
1,423,739
+189,304
+15% +$287K 0.03% 670
2022
Q1 		$2.51M Buy
1,234,435
+346,653
+39% +$545K 0.07% 305
2021
Q4 		$1.96M Buy
887,782
+757,578
+582% +$1.85M 0.06% 330
2021
Q3 		$388K Buy
+130,204
New +$272K 0.01% 897

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Walleye Capital's SRTAW Position: Q1 2025 in Review

Walleye Capital sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2025, closing a stake of 188,816 shares — an estimated $77.4K sold.

Walleye Capital first reported a position in SRTAW in Q3 2021 and held it in 14 quarters. The position peaked at $2.51M in Q1 2022. 6 funds tracked by Wall St. Rank hold SRTAW as of Q1 2025.

  • Walleye Capital reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 188,816 Strata Critical Medical Inc Warrants shares in Q1 2025, an estimated $77.4K.
  • Walleye Capital first reported a position in Strata Critical Medical Inc Warrants in Q3 2021 and held it in 14 quarters.
  • Walleye Capital's Strata Critical Medical Inc Warrants position peaked at $2.51M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.